Lin-Kun Shen

2PUBLICATIONS
3CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 13, 2024
Correction: Liu et al. Endostatin 33 Peptide Is a Deintegrin α6β1 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer. J. Clin. Med. 2023, 12, 1861.

Yang Liu, Chang-Lin Wang, Zhong-Qi Pang

|Mar 11, 2023
Endostatin 33 Peptide Is a Deintegrin α6β1 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer.

Yang Liu, Chang-Lin Wang, Zhong-Qi Pang

Pageof 1

Frequent Collaborators

2 joint publications

Yang Liu

2 joint publications

Zhong-Qi Pang

2 joint publications

Ming-Hua Ren